Potentiation of warfarin by interferon

BMJ

Volumn 311, Issue 7000, 1995, Pages 292-

  Adachi, Y ^a   Yokoyama, Y ^a   Nanno, T ^a   Yamamoto, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MICROSOME ENZYME; WARFARIN;

ANTICOAGULATION; ARTICLE; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG POTENTIATION; HEPATITIS C; HUMAN; LIVER FUNCTION TEST; PRIORITY JOURNAL; THROMBOTEST;

BLOOD COAGULATION DISORDERS; CASE REPORT; DRUG SYNERGISM; FEMALE; HEPATITIS C; HUMAN; INTERFERONS; MIDDLE AGE; WARFARIN;

EID: 0029103036     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.311.7000.292a     Document Type: Article

References (6)

1. Smith P Arnesen H Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147–52.
2. Irie T Okazaki H. General pharmacological studies on HLBI(SM-5000)–effect on coagulation fibrinolysis system. Clinical Report 1987; 17: 6397–9. [In Japanese.]
3. Renton KW Singh G Stebbing N. Relationship between the antiviral effects of interferons and their abilities to depress cytochrome P-450. Biochem Pharmacol 1984; 33: 3899–902.
4. Okuno H Kitao Y Takasu M Kunieda K Seki T Shiozaki T, et al. Depression of drug metabolizing activity in the human liver by interferon-(alpha). Eur J Clin Pharmacol 1990; 39: 365–7.
5. Williams SJ Baird-Lambert JA Farrell GC. Inhibition of theophylline metabolism by interferon. Lancet 1987; ii: 939–41.
6. Okuno H Takasu M Kano H Seki T Shiozaki Y Inoue K. Depression of drugmetabolising activity in the human liver by interferon beta. Hepatology 1993; 17: 65–9.